Thiadiazoloquinoxaline derivatives

US10738240B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10738240-B2
Application numberUS-201615571645-A
CountryUS
Kind codeB2
Filing dateApr 13, 2016
Priority dateMay 6, 2015
Publication dateAug 11, 2020
Grant dateAug 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

to processes and intermediates for the preparation thereof, to the use of the compounds of the formula I for optical, electro-optical and electronic purposes, in particular in liquid-crystal media and in devices for regulating the passage of energy from an outside space into an inside space, and to these LC media and the devices comprising these media.

First claim

Opening claim text (preview).

The invention claimed is: 1. A guest-host liquid crystalline medium comprising a dye component A) which comprises one or more compounds of the formula I and a liquid-crystalline component B) which comprises one or more mesogenic compounds in which W denotes S or Se, X 11 , X 12 , identically or differently, denote H, alkyl having 1-6 C atoms, in which one or more H atoms may be replaced by F and one or more CH 2 groups may be replaced by —O— or —S— in such a way that no O or S atoms are adjacent, perfluoroalkyl having 1-6 C atoms, halogen, CN, SF 5 , an aryl or heteroaryl group, which may be substituted by one or more radicals L, and alternatively the groups X 11 and X 12 together also denote a straight-chain or branched alkylene group having 2 to 10 C atoms, in which one, several or all H atoms may be replaced by F, R 11 , R 12 , identically or differently, denote F, straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH 2 groups may each be replaced, independently of one another, by —C(R z )═C(R z )—, —C≡C—, —N(R z )—, —O—, —S—, —C(O)—, —C(O)—O—, —O—C(O)— or —O—C(O)—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, Br, I or CN, R z on each occurrence, identically or differently, denotes H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH 2 groups may be replaced by —O—, —S—, —C(O)—, —C(O)—O—, —O—C(O)— or —O—C(O)—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F or Cl, A 11 , A 12 each, independently of one another, denote an aryl or heteroaryl group, which may be substituted by one or more radicals L, A 21 , A 22 are each, independently of one another, defined like A 11 or denote a cyclic alkyl group having 3 to 10 C atoms, in which 1 to 4 CH 2 groups may be replaced by O in such a way that no two O atoms are adjacent, L on each occurrence, identically or differently, denotes OH, CH 2 OH, F, Cl, I, —CN, —NO 2 , SF 5 , —NCO, —NCS, —OCN, —SCN, —C(═O)N(R z ) 2 , —C(═O)R z , —N(R z ) 2 , optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, Z 11 , Z 12 on each occurrence, identically or differently, denote a single bond, —CR x1 ═CR x2 —, —C≡C— or —C(O)—, Z 21 , Z 22 are on each occurrence, identically or differently, defined like Z 11 or denote —O—, —S—, —CR y1 R y2 —, —CF 2 O—, —OCF 2 —, —C(O)—O—, —O—C(O)—, —O—C(O)—O—, —OCH 2 —, —CH 2 O—, —SCH 2 —, —CH 2 S—, —CF 2 S—, —SCF 2 —, —(CH 2 ) n1 —, —CF 2 CH 2 —, —CH 2 CF 2 —, —(CF 2 ) n1 —, —CH═CH—COO— or —OCO—CH═CH—, R x1 , R x2 , independently of one another, denote H, F, Cl, CN or alkyl having 1-12 C atoms, R y1 , R y2 each, independently of one another, denote H or alkyl having 1-12 C atoms, r, s, independently of one another, denote 0, 1, 2 or 3, n1 denotes 1, 2, 3 or 4, with the proviso that the compound of the formula is excluded. 2. A liquid crystalline medium according to claim 1 , wherein in formula I, if r and s are identical, at least one of the groups A 11 and A 12 , or R 11 and R 12 , or A 21 and A 22 , or Z 11 and Z 12 , or Z 21 and Z 22 , or X 11 and X 12 is different from one another, where the parameters have the meanings indicated in claim 1 . 3. A liquid crystalline medium according to claim 1 , wherein in formula I, r denotes 0, 1 or 2 and s denotes r+1. 4. A liquid crystalline medium according to claim 1 , wherein in formula I, W denotes —S—. 5. A liquid crystalline medium according to claim 1 , wherein in formula I, X 11 and X 12 each, independently of one another, denote H, CH 3 , C 2 H 5 , F, Cl, CF 3 , OCF 3 , CN or together denote 1,4-butylene, 1,3-hexafluoropropylidene or 1,4-octafluorobutylidene. 6. A liquid crystalline medium according to claim 1 , wherein in formula I, A 11 , A 12 , A 21 , A 22 are selected on each occurrence, identically or differently, from groups, optionally substituted by radicals L, derived from the parent substances benzene, fluorene, naphthalene, pyridine, pyrimidine, thiophene, thiazole, dihydrothienodioxin, benzothiophene, dibenzothiophene, benzodithiophene, cyclopentadithiophene, thienothiophene, indenothiophene, furan, benzofuran, dibenzofuran and quinoline, where L is selected from the groups F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 and phenyl. 7. A liquid crystalline medium according to claim 1 , wherein the compounds of formula I, are selected from the following sub-formulae: in which R 11 , R 12 , independently of one another, denote F, a straight-chain alkyl or alkoxy group having 1 to 15 C atoms or a branched alkyl or alkoxy group having 3 to 20 C atoms, in which, in addition, one or more H atoms may be replaced by F, A 11 , A 12 , A 21 , A 22 each, independently of one another, denote 1,4-phenylene, 2,6-naphthylene, thiophene-2,5-diyl or thiazole-2,5-diyl, Z 21 , Z 22 , independently of one another, denote —CH 2 CH 2 —, —CF 2 CF 2 —, —CH═CH—, —CF═CF—, —OCH 2 —, —CH 2 O—, —OCF 2 —, —CF 2 O— or a single bond, L on each occurrence, identically or differently, denotes OH, CH 2 OH, F, Cl, I, —CN, —NO 2 , SF 5 , —NCO, —NCS, —OCN, —SCN, —C(═O)N(R z ) 2 , —C(═O)R z , —N(R z ) 2 , optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F or Cl, a, independently of one another, denotes 0, 1, 2, 3 or 4, b, independently of one another, denotes 0, 1 or 2, c, independently of one another, denotes 0 or 1, and d, independently of one another, denotes 1, 2, 3, 4, 5 or 6. 8. A liquid crystalline medium according to claim 1 , wherein in formula I, Z 21 and Z 22 denote a single bond. 9. A method which comprises including a liquid crystalline medium according to claim 1 in electro-optical displays, devices for regulating the passage of energy from an outside space into an inside space, electrical semiconductors, organic field-effect transistors (OFETs), printed circuits, radio frequency identification elements (RFIDs), organic light-emitting diodes (OLEDs), lighting elements, photovoltaic devices, optical sensors, effect pigments, decorative elements or as dye for colouring polymers. 10. A process wherein compounds of the formula III are converted into compounds of the formula I according to claim 1 ,

Assignees

Inventors

Classifications

  • Pleochroic dyes · CPC title

  • containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur, e.g. silicon, metals · CPC title

  • used in the technical field of thermotropic switches · CPC title

  • the heterocyclic ring containing sulfur and nitrogen atoms · CPC title

  • characterised by components which are not liquid crystals, e.g. additives {with special physical aspect: solvents, solid particles} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10738240B2 cover?
to processes and intermediates for the preparation thereof, to the use of the compounds of the formula I for optical, electro-optical and electronic purposes, in particular in liquid-crystal media and in devices for regulating the passage of energy from an outside space into an inside space, and to these LC media and the devices comprising these media.
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/3497. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).